On August 3, 2015, Aprecia Phramaceuticals, announced that the U.S. Food and Drug Administration (FDA) approved itâs SPRITAM drug for the treatment of epilepsy. The company claims that SPRITAM is the first drug ever approved by the FDA that is manufactured using 3-D printing technologies. Aprecia Pharmaceuticals announced that its epilepsy drug SPRITAM was the first drug approved by the FDA that is manufactured with 3-D printing technologies. (Image Credit: Aprecia Pharmaceuticals) âBy combining 3-D printing technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,â said Don Wetherhold, Aprecia CEO.
Autistic disorder, sometimes called autism or classical ASD, is the most severe form of ASD, while other conditions along the spectrum include a milder form known as Asperger syndrome, and childhood disintegrative disorder and pervasive developmental disorder not otherwise specified (usually referred to as PDD-NOS).utistic disorder, sometimes called autism or classical ASD, is the most severe form of ASD, while other conditions along the spectrum include a milder form known as Asperger syndrome, and childhood disintegrative disorder and pervasive developmental disorder not otherwise specified (usually referred to as PDD-NOS).
The bipolar spectrum is a term used to refer to conditions that include not only bipolar disorder as traditionally defined ( that is , clear episodes of mania or hypomania as well as depressive syndromes ) but also other types of mental conditions that can involve depression or mood swings without manic or hypomanic episodes -- including some ...